The Flowr Corporation

OTC: FLWPF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONCIK 0001752524Reports USD

#1 of 1,402 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 16

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, Altman-Z · ↓ market scale, listing tenure

Methodology →

Revenue TTM

$9.3M

Rev growth YoY (TTM)

+15.7%

Net income (FY)

—

Employees

—

Market cap

$4.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

The Flowr Corporation has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Kaleido Biosciences, Inc.——ONE Bio Corp.——Emergent Health Corp——Baudax Bio, Inc.——

Key facts

CEOSteven Adam Klein

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: FLWPF

Employees—

IPO date2021-01-08

Latest filings

6-K2019-07-16 6-K2019-07-15

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.